Hugh M Cole Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Hugh M Cole.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Hugh M Cole. Hugh M Cole is a SVP, Chief Business Officer in ARIAD PHARMACEUTICALS INC ($ARIA) and a Director in CATABASIS PHARMACEUTICALS INC ($CATB) and a Chief Business Officer in Jounce Therapeutics, Inc. ($JNCE).

Address: C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE 02139 MA

Companies in which Hugh M Cole is an Insider

ARIAD PHARMACEUTICALS INC

Trading Symbol: ARIA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Hugh M Cole: SVP, Chief Business Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 16 2017
$ARIA Market Capitalization: $4.64B
$ARIA Previous Close: $23.81

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CATABASIS PHARMACEUTICALS INC

Trading Symbol: CATB
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Hugh M Cole: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 12 2020
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Jounce Therapeutics, Inc.

Trading Symbol: JNCE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Hugh M Cole: Chief Business Officer
Holdings: 73,889 shares
Current Value: $1,278,280
Latest Transaction: Feb 03 2021
$JNCE Market Capitalization: $140.99M
$JNCE Previous Close: $17.30

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Hugh M Cole

Sentiment: All, ARIA, CATB, JNCE

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 03 2021JNCEJounce Therapeutic ...Cole Hugh MChief Business Offi ...Option ExerciseA11.8953,400634,92653,400
Feb 03 2021JNCEJounce Therapeutic ...Cole Hugh MChief Business Offi ...GrantA0.0026,700073,88947.2 K to 73.9 K (+56.58 %)
Jan 25 2021JNCEJounce Therapeutic ...Cole Hugh MChief Business Offi ...Option ExerciseM6.555,00032,75055,000
Jan 25 2021JNCEJounce Therapeutic ...Cole Hugh MChief Business Offi ...Option ExerciseM4.405,00022,00039,500
Jan 25 2021JNCEJounce Therapeutic ...Cole Hugh MChief Business Offi ...SellS11.9518,000215,10047,18965.2 K to 47.2 K (-27.61 %)
Jan 25 2021JNCEJounce Therapeutic ...Cole Hugh MChief Business Offi ...BuyM6.555,00032,75065,18960.2 K to 65.2 K (+8.31 %)
Jan 25 2021JNCEJounce Therapeutic ...Cole Hugh MChief Business Offi ...BuyM4.405,00022,00060,18955.2 K to 60.2 K (+9.06 %)

View all Hugh M Cole insider transactions.